Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Texas Biotech (TXB) -- Ignore unavailable to you. Want to Upgrade?

To: Bharat H. Barai who wrote (445)	12/26/1997 8:58:00 PM
From: Dauntless	Respond to of 834

Dr. Barai, Your post was accurate, informative and, I'm afraid, wasted on this individual. He works with an unscrupulous wall street firm, whose specialty is to first take a short position & then proceed to attempt to tear them down by scaring small investors with an endless series of lies & accusations aimed at management, investors, market makers, etc. He has no interest in the comlpetely accurate facts you posted. He will ignore them & continue to post his lies. Check out the Zonagen thread over the past month or so & see for yourself.

To: Bharat H. Barai who wrote (445)	12/27/1997 4:44:00 AM
From: Bill Wexler	Read Replies (1) \| Respond to of 834

<<One of them showed positive trend but did not show statistically significant difference (I think that is the one you are referring to in your post). The present Product Licence Application (PLA) filed with FDA is NOT for Cardio Vascular indication but for Heparin induced Thrombocytopenia (HIT). This multi center trial showed highly statistical significat dfference (This trial data were presented at International Hematology meeting in Milan, Italy in June, 1997).>> Correct on count one. I completely disagree that the HIT trials showed statistically significant positive response. As far as the two new drugs are concerned. TXB's multi-year track record of delivering lots of promises but no product speaks for itself. Don't bet what you can't afford to lose.